Mounjetra 2.5

Mounjetra® is an advanced Tirzepatide-based injectable therapy designed to support safe, sustainable weight management. Formulated using clinically proven GLP-1 and GIP dual agonist technology, it helps regulate appetite, improve metabolic balance, and promote gradual, healthy fat loss.

Each 2.5mg cartridge delivers precisely measured dosing, ensuring consistent and effective results.

Key Benefits:

• Dual-action formula for improved weight and glucose control

• Reduces hunger and promotes longer satiety

• Designed for once-weekly subcutaneous administration

• Suitable for doctor-supervised personalized treatment plans